Sana prices at near record IPO, leading pack of Nasdaq newcomers
In a week where 10 biotechs are expected to price their IPOs, three companies kicked things off with a bang.
Sana Biotechnology priced late Wednesday night at $25 per share, announcing it had raised a whopping $587.5 million. Joining Sana on the Nasdaq are Landos Biopharma and Sensei Biotherapeutics, raising $100 million and $133 million each while pricing at $16 and $19, respectively.
Once their stocks officially go live, they will use the tickers {$SANA), $LABP and $SNSE.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
